Im Cannabis Ownership
| IMCC Stock | USD 0.56 0.04 6.67% |
Shares in Circulation | First Issued 1997-06-30 | Previous Quarter 13.4 M | Current Value 13.4 M | Avarage Shares Outstanding 1.6 M | Quarterly Volatility 3.5 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
IMCC |
IMCC Stock Ownership Analysis
About 36.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.77. Some equities with similar Price to Book (P/B) outperform the market in the long run. Im Cannabis Corp recorded a loss per share of 0.81. The entity last dividend was issued on the 18th of June 2018. The firm had 1:10 split on the 17th of November 2022. IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. The company serves medical patients and adult-use recreational consumers. IM Cannabis is traded on NASDAQ Exchange in the United States. To learn more about Im Cannabis Corp call Oren Shuster at 972 5 44331111 or check out https://www.imcannabis.com.Besides selling stocks to institutional investors, Im Cannabis also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Im Cannabis' stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Im Cannabis' strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Im Cannabis Quarterly Liabilities And Stockholders Equity |
|
About 36.0% of Im Cannabis Corp are currently held by insiders. Unlike Im Cannabis' institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Im Cannabis' private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Im Cannabis' insider trades
IMCC Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Im Cannabis is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Im Cannabis Corp backward and forwards among themselves. Im Cannabis' institutional investor refers to the entity that pools money to purchase Im Cannabis' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 4.0 | Advisor Group Holdings, Inc. | 2023-12-31 | 4.0 | Concord Wealth Partners | 2023-12-31 | 0.0 | Scotia Capital Inc | 2024-03-31 | 0.0 | North Star Investment Management Corp | 2023-12-31 | 0.0 | Lynwood Capital Management Inc. | 2024-03-31 | 0.0 | Emc Capital Management(tx) | 2024-03-31 | 0.0 | Black Maple Capital Management Lp | 2024-03-31 | 400 K | Advisorshares Investments, Llc | 2023-12-31 | 247.5 K | Bank Of Montreal | 2023-12-31 | 71.4 K | Bmo Capital Markets Corp. | 2023-12-31 | 71.4 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Im Cannabis Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Im Cannabis' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Im Cannabis Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Im Cannabis Corp Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Im Cannabis Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Im Cannabis Corp information on this page should be used as a complementary analysis to other Im Cannabis' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Complementary Tools for IMCC Stock analysis
When running Im Cannabis' price analysis, check to measure Im Cannabis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Im Cannabis is operating at the current time. Most of Im Cannabis' value examination focuses on studying past and present price action to predict the probability of Im Cannabis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Im Cannabis' price. Additionally, you may evaluate how the addition of Im Cannabis to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |
Is Im Cannabis' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Im Cannabis. If investors know IMCC will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Im Cannabis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.81) | Revenue Per Share 3.623 | Quarterly Revenue Growth (0.04) | Return On Assets (0.15) | Return On Equity (0.94) |
The market value of Im Cannabis Corp is measured differently than its book value, which is the value of IMCC that is recorded on the company's balance sheet. Investors also form their own opinion of Im Cannabis' value that differs from its market value or its book value, called intrinsic value, which is Im Cannabis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Im Cannabis' market value can be influenced by many factors that don't directly affect Im Cannabis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Im Cannabis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Im Cannabis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Im Cannabis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.